New Trial to Study Asthma Drug Responses, Genetic Factors in African-Americans | GenomeWeb

NEW YORK (GenomeWeb News) — The National Heart, Lung, and Blood Institute has launched a multi-site clinical trial to assess how African-Americans with asthma respond to different therapies, and to examine the genetics at play in those responses, NHLBI said today.

The Best African American Response to Asthma Drugs (BARD) study will enroll roughly 500 children and adults at 30 sites in 14 states to research their responses to varying combinations of medications and dosages and how genes may affect those responses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.